Home
>
National Drug Code (NDC)
>
GlyBURIDE
GlyBURIDE - 67253-461-50 - (GlyBURIDE)
Drug Information of GlyBURIDE
| Product NDC: | 67253-461 |
| Proprietary Name: | GlyBURIDE |
| Non Proprietary Name: | GlyBURIDE |
| Active Ingredient(s): | 3 mg/1 & nbsp; GlyBURIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GlyBURIDE
| Product NDC: | 67253-461 |
| Labeler Name: | DAVA Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074591 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19971222 |
Package Information of GlyBURIDE
| Package NDC: | 67253-461-50 |
| Package Description: | 500 TABLET in 1 BOTTLE (67253-461-50) |
NDC Information of GlyBURIDE
| NDC Code | 67253-461-50 |
| Proprietary Name | GlyBURIDE |
| Package Description | 500 TABLET in 1 BOTTLE (67253-461-50) |
| Product NDC | 67253-461 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | GlyBURIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19971222 |
| Marketing Category Name | ANDA |
| Labeler Name | DAVA Pharmaceuticals, Inc. |
| Substance Name | GLYBURIDE |
| Strength Number | 3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |
